1. Home
  2. SMID vs SPRO Comparison

SMID vs SPRO Comparison

Compare SMID & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • SPRO
  • Stock Information
  • Founded
  • SMID 1960
  • SPRO 2013
  • Country
  • SMID United States
  • SPRO United States
  • Employees
  • SMID N/A
  • SPRO N/A
  • Industry
  • SMID Building Materials
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMID Industrials
  • SPRO Health Care
  • Exchange
  • SMID Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • SMID 157.4M
  • SPRO 164.4M
  • IPO Year
  • SMID 1995
  • SPRO 2017
  • Fundamental
  • Price
  • SMID $37.91
  • SPRO $2.78
  • Analyst Decision
  • SMID
  • SPRO Buy
  • Analyst Count
  • SMID 0
  • SPRO 4
  • Target Price
  • SMID N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • SMID 21.7K
  • SPRO 1.3M
  • Earning Date
  • SMID 07-10-2025
  • SPRO 08-04-2025
  • Dividend Yield
  • SMID N/A
  • SPRO N/A
  • EPS Growth
  • SMID 444.88
  • SPRO N/A
  • EPS
  • SMID 1.86
  • SPRO N/A
  • Revenue
  • SMID $84,450,000.00
  • SPRO $44,584,000.00
  • Revenue This Year
  • SMID N/A
  • SPRO N/A
  • Revenue Next Year
  • SMID N/A
  • SPRO N/A
  • P/E Ratio
  • SMID $20.57
  • SPRO N/A
  • Revenue Growth
  • SMID 33.01
  • SPRO N/A
  • 52 Week Low
  • SMID $25.13
  • SPRO $0.51
  • 52 Week High
  • SMID $51.96
  • SPRO $3.22
  • Technical
  • Relative Strength Index (RSI)
  • SMID 71.21
  • SPRO 60.75
  • Support Level
  • SMID $32.85
  • SPRO $2.89
  • Resistance Level
  • SMID $35.37
  • SPRO $3.22
  • Average True Range (ATR)
  • SMID 1.63
  • SPRO 0.13
  • MACD
  • SMID 0.51
  • SPRO -0.07
  • Stochastic Oscillator
  • SMID 82.07
  • SPRO 12.64

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: